Gait Dysfunction in Motoric Cognitive Risk Syndrome.

Abstract

BACKGROUND\nMotoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established.\n\n\nOBJECTIVE\nTo systematically assess clinical gait abnormalities in older adults with MCR.\n\n\nMETHODS\nOf the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47% women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n\u200a=\u200a41), slow swing time (MCRsw, n\u200a=\u200a21), high stride length variability (MCRslv, n\u200a=\u200a24), and high swing time variability (MCRswv, n\u200a=\u200a25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n\u200a=\u200a81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases.\n\n\nRESULTS\nMost clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61%). Neurological (range 24 to 46%) and non-neurological gait abnormalities (33 to 61%) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46%) and non-neurological gaits in MCRv (61%). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value\u200a=\u200a0.033) but not decline on cognitive scores (p-value\u200a=\u200a0.056).\n\n\nCONCLUSION\nClinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.